氯维地平 T0999
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 167221-71-8 | ¥435.00 | 询底价 |
25 mg | 167221-71-8 | ¥759.00 | 询底价 |
1 mL | 167221-71-8 | ¥479.00 | 询底价 |
5 mg | 167221-71-8 | ¥263.00 | 询底价 |
100 mg | 167221-71-8 | ¥1,920.00 | 询底价 |
500 mg | 167221-71-8 | ¥3,980.00 | 询底价 |
50 mg | 167221-71-8 | ¥1,263.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Clevidipine
描述: Clevidipine (Clevidipine butyrate) butyrate 是一种二氢吡啶 L 型钙通道阻滞剂,IC50为7.1 nM。它对血管平滑肌有选择性,可用于降低血压。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: Ethanol : 3 mg/mL (6.57 mM)
DMSO : 84 mg/mL (184.1 mM)
关键字: Ca2+ channels | Ca channels | inhibit | Calcium Channel | Clevidipine Butyrate | Clevidipine | Inhibitor
相关产品: ABT-639 | YM 244769 hydrochloride | Ambocin | YM-58483 | Ethyl cinnamate | Vindorosine | CDN1163 | Calcium Channel antagonist 3 | Ranolazine | Norverapamil hydrochloride
相关库: Drug Repurposing Compound Library | ReFRAME Related Library | Drug-induced Liver Injury (DILI) Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Metabolism Compound Library | Autophagy Compound Library
氯维地平 T0999信息由TargetMol中国为您提供,如您想了解更多关于氯维地平 T0999报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途